Growth and Pituitary-Adrenal Function in Children with Severe Asthma Treated with Inhaled Budesonide
Open accessThe DOI matches its Crossref record.
Abstract
BACKGROUND: The increased use of inhaled corticosteroids in the management of asthma raises concern about the safety of these drugs in children. We sought to determine the safety of long-term administration of inhaled budesonide in young children with asthma. METHODS: We studied 15 children 2 to 7 years old who had severe perennial asthma. They inhaled 100 micrograms of budesonide twice daily for three to five years. Efficacy was assessed by serial evaluation of respiratory symptoms and the need for other medications, and safety by serial evaluation of height, height velocity, weight, bone age, and pituitary-adrenal function. RESULTS: The severity of asthma decreased within the first month after the initiation of therapy, as demonstrated by a 58 percent reduction in the number of days with symptoms of asthma and a 75 percent decrease in the use of bronchodilators. This improvement was maintained thereafter. The growth pattern of all patients, including their height, weight, and bone age, was normal (as compared with standard normal values) throughout the treatment period. Pituitary-adrenal function was not adversely affected by the treatment, as demonstrated by normal serum cortisol concentrations in the morning and 60 minutes after stimulation with corticotropin, normal 24-hour serum cortisol concentrations (mean [+/- SD] of samples collected at 30-minute intervals for 24 hours, 8.4 +/- 4.2 micrograms per deciliter [232 +/- 116 nmol per liter]), and normal urinary cortisol excretion (34 +/- 9 micrograms [95 +/- 25 nmol] per day). CONCLUSIONS: Prolonged administration of 200 micrograms of inhaled budesonide daily to young children with severe asthma does not impair growth or pituitary-adrenal function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Efficacy and Safety of Inhaled Corticosteroids: New Developments
BARNES, P. J., PEDERSEN, S., & BUSSE, W. W. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.3.157315 · Cited by 749
Inhaled Glucocorticoids for Asthma
Barnes, P. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503303321307 · Cited by 629
Third International Pediatric Consensus statement on the management of childhood asthma
Warner, J. O., Naspitz, C. K., & Cropp, G. J. A. (1998) · Pediatric Pulmonology · doi:10.1002/(sici)1099-0496(199801)25:1<1::aid-ppul1>3.0.co;2-s · Cited by 389
A comparison of the efficacy and safety of inhaled corticosteroids in asthma
Pedersen, S., & O'Byrne, P. (1997) · Allergy · doi:10.1111/j.1398-9995.1997.tb05047.x · Cited by 352
A Comparison of Beclomethasone, Salmeterol, and Placebo in Children with Asthma
Simons, F. E. R. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712043372304 · Cited by 326
Metadata
- Authors
- Volovitz, B., Amir, J., Malik, H., Kauschansky, A., & Varsano, I.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1993-12-02
- Volume
- 329
- Issue
- 23
- Pages
- 1703-1708
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2340839178
- Cited by
- 148
- References
- 0
- FWCI
- 6.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Growth and Pituitary-Adrenal Function in Children with Severe Asthma Treated with Inhaled Budesonide. https://app.cochat.ai/papers/10.1056/nejm199312023292305
- The paper
- Volovitz, B., Amir, J., Malik, H., Kauschansky, A., & Varsano, I. (1993). Growth and Pituitary-Adrenal Function in Children with Severe Asthma Treated with Inhaled Budesonide. New England Journal of Medicine. https://doi.org/10.1056/nejm199312023292305
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.